Nice Flashcards

1
Q

Explain the reduction in fertility associated with thalassaemia ?
How to manage?

A

๐Ÿ”ดIn transfusion dependent women where chelation has been suboptimal ๐Ÿ‘‰ iron overload
๐Ÿ‘‰ damage to the anterior pituitary
๐Ÿ”ด they require ovulation induction using injectable gonadotrophins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the optimum preconceptual care for women with thalassaemia?

A

1-Screening for end organ damage
2- optimization of complications prior to pregnancy.
3- review transfusion requirements
4-compliance with chelation therapy
5- assessment of body iron burden

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the contraceptions that may be used in women with thalassaemia?

A

Any contraindications ( OC-pop- implants- mirena)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Are there any interventions which are beneficial at preconceptual stage ?

A

Aggressive chelation: can reduce iron burden and reduce end organ damage.
(โฌ‡๏ธ endocrinopathy / โฌ‡๏ธ cardiac problems).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why it is necessary to optimize iron burden prepregnancy?

A

Because: all chelation therapy should be regarded as potential teratogenic in the first trimester.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What chelation agent has evidence for use in 2nd & 3rd trimester?

A

Desferrioxamine
* has a short half life
* safe for infusion during ovulation induction
* safe after 20 weeks at low doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Since diabetes is common in women with thalassaemia.. how to consult a diabetic women with thalassaemia prepregnancy?

A

Should have serum Fructosamine concentrations < 300 for at least 3 months prior to conception
Equivalent to HbA1c of 43 mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why serum fructosamine is preferred for monitoring diabetic women with thalassaemia?

A

Because HbA1c may diluted by transfused blood and the results in underestimation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How to preform screening organ damage in women with thalassaemia preconception?

A

1- pancreas: ๐Ÿ‘‰ diabetes
2- thyroid; thyroid functions
3- heart: echocardiogram & ECG
T2 cardiac MRI
4- liver : -assess liver iron concentration using FerriScan/ liver T2
- ultrasound for liver and gallbladder
5- Bone density scan
6- serum vit D
7- red cells antibodies: ABO and full blood group genotype and antibody titres

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How to asses the cardiac status in women with thalassaemia preconception?

A

๐Ÿ›‘All women should be assessed by cardiologist expertise in iron overload.,prior to pregnancy
โค By : 1- echocardiogram ( cardiomyopathy)
2- ECG ( arrhythmias)
3- T2 cardiac MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How to asses liver status in women with thalassaemia preconception?

A

1- Women should be assessed for liver iron concentration using : FerriScan or liver T2
2 - liver and gallbladder ultrasound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Liver and gallbladder ultrasound in women with thalassaemia is used to detect what?

A

1- cholelithiasis
2-liver cirrhosis due to iron overload
3- transfusion related viral hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the target of liver iron in women with thalassaemia before pregnancy?

A

Should be less than 7 mg/ g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

If liver iron exceeds 15 mg/g prior to conception.. what is the management in pregnancy?

A

Iron chelation with low dose of desferrioxamine between 20-28 weeks
( because the risk of increased myocardial iron loading)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What makes osteoporosis a common finding in women with thalassaemia?

A
  • underlying thalassaimic bone disease
  • chelation of Ca by chelation drugs
  • hypothyroidism
  • Vit D deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the prevalence of allo immunity in individuals with thalassaemia?

A

16% ๐Ÿ‘‰ indicate a risk of hemolytic disease of the fetus & newborn
๐Ÿ‘‰ may be challenges in obtaining suitable blood for transfusion.

17
Q

What medications should be reviewed preconcepually in women with thalassaemia?

A

*Iron chelators: - deferasirox oral
- deferiprone oral
( women should be converted to
Desferrioxamine subcutaneous)
* bisphosphonate
๐Ÿ›‘ should ideally be discontinued
3 months prior to conception

18
Q

What is the role of genetic screening in women with thalassaemia?

A

PGD should be considered in the presence of haemoglobinopathies in both partners so that :
A homozygous /
Compound heterozygous
Can be avoided

19
Q

What are the conditions in the partner that require counseling if the mother is affected by thalassaemia?

A

risk of serious haemoglobinopathy :
- B thalassaemia
- HbS
- HbE
- delta bata thalassaemia
- Hb lepore
- HbO arab
- Hb constant spring
Risk of mild to moderate haemoglobinopathy:
- HbC
- other variant haemoglobin

20
Q

What is the importance of immunization in women who are transfused ?

A
  • Hepatitis B vaccination
  • determine Hepatitis C status ( common & asymptomatic)
    • If positive ๐Ÿ‘‰ RNA titres should
      be determined
21
Q

What is the importance of immunization/ Antibiotics prophylaxis in women who have had splenectomy?

A
  • daily penicillin prophylaxis: high risk of infection from encapsulated bacteria As: - Neisseria meningitis
    -Streptococcus Pneumonia
    - Haemophilus influenza type b
  • vaccination for :
    • Haemophilus influenza type b
    • conjugated meningococcal C
      Single dose
      -pneumococcal vaccine: every 5 y
22
Q

What vitamin supplements should be recommended preconceptually to women with thalassaemia?

A

Folic acid 5 mg / d ( 3 months)

23
Q

How is antenatal care provided to women with thalassaemia?

A

1- visits : monthly until 28 weeks and fortnightly thereafter.
2- thalassaemia major ๐Ÿ‘‰ cardiac assessment at 28 w
3- women with diabetes ๐Ÿ‘‰ monthly -assessment of serum Fructosamine
- review in diabetic pregnancy clinic
4- women with hypothyroidism ๐Ÿ‘‰ monitor thyroid function

24
Q

What is the recommended schedule of US during pregnancy in women with thalassaemia?

A

Should be offered:
- early scan 7-9 w ( high risk of early pregnancy loss)
- routine 11-14 w
- routine anomaly scan 18-20 w
-From 24 w : every 4 w

25
Q

How should the transfusion regimen be managed during pregnancy in women with thalassaemia major?

A

โค should be receiving blood transfusions on regular basis
Aim : pretransfusion Hb of 10

26
Q

How should the transfusion regimen be managed during pregnancy in women with thalassaemia intermedia ?

A

Consider regular transfusion if :
- worsening maternal anaemia
- evidence of FGR
โค woman asymptomatic with normal fetal growth and low Hb :
**Should be assessed in late pregnancy:
* Hb > 8 at 36 w : avoid transfusion
* Hb < 8 : 2 units at 37-38 w

27
Q

What antenatal thromboprophylaxis is recommended in women with thalassaemia?

A

โคAspirin 75 mg / d:
- who have undergone splenectomy
OR - have plt count > 600,000
โค LMWH + Aspirin:
- who have undergone splenectomy
AND - have plt count > 600,000

28
Q

Among pregnant women with thalassaemia who are in the highest risk of venous thromboembolism?

A

Splenectomised women with thalassaemia intermedia who are not receiving transfusions
โ– { good transfusion regimen suppresses endogenous erythropoiesis}โ– 

29
Q

What is the optimum antenatal management of women with myocardial iron?

A
  • regular cardiology review
  • monitor cardiac EF
    If the woman describes symptoms:
    Palpitations- breathlessness- syncope- orthopnoea- peripheral oedema:
    1- echocardiography: โฌ‡๏ธEF / increasing ventricular volume ๐Ÿ‘‰ increasing risk of heart failure
    2- 24h ECG
    3- cardiac MRI
30
Q

What are the cardiac MRI findings in women with myocardial iron?

A

T2 > 20 ms๐Ÿ‘‰donโ€™t require chelation
T2 < 20 ms๐Ÿ‘‰increasing risk of cardiac decompensation
T2< 10 ms๐Ÿ‘‰at high risk of cardiac decompensation

31
Q

What is the optimum management of women at highest risk of cardiac decompensation?

A

Low dose subcutaneous desferrioxamine on a minimum of
4-5 days/ week from 20-24 w

32
Q

What is the optimum management of women with liver iron ?

A

Consider low dose of subcutaneous desferrioxamine from 20 w
๐Ÿ”ดIf liver iron > 15 mg/ g dw ( MRI)
To reduce the risk of myocardial iron overload.

33
Q

What is the best intrapartum management for women with thalassaemia major or intermedia ?

A

1-No complications ( as diabetes/ FGR/ cardiomyopathy..) ๐Ÿ‘‰aim for vaginal birth. [ inform multidisciplinary team as soon as the woman is admitted]
2- continuous CTG
3- in the presence of ABO antibodies
+ Hb< 10 ๐Ÿ‘‰cross match 2 units
In the absence of ABO antibodies
+ Hb< 10 ๐Ÿ‘‰ group and save blood
4- in thalassaemia major ๐Ÿ‘‰ IV desferrioxamine 2g/ 24 h in labour
5- Active management for the third stage.

34
Q

What is the major risk in women with thalassaemia post delivery?

A

Venous thromboembolism:
LMWH in hospital and after discharge;
* 7 days post discharge ( vaginal delivery)
* 6 weeks post discharge ( CS )

35
Q

What should be the optimum care regarding breastfeeding?

A

Breastfeeding ๐Ÿ‘‰restart desferrioxamine as soon as the initial 24h IV finishes
Not breastfeed ๐Ÿ‘‰IV or subc desferrioxamine until discharging